|Bid||4.5800 x 1400|
|Ask||4.7100 x 800|
|Day's Range||4.5700 - 4.6800|
|52 Week Range||4.3600 - 18.8000|
|Beta (5Y Monthly)||2.34|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov 03, 2021 - Nov 08, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||21.25|
NEW YORK, NY / ACCESSWIRE / September 20, 2021 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies who purchased shares within the class periods listed below. Shareholders interested in representing the class of wronged shareholders have until the lead plaintiff deadline to petition the court.
NEW YORK, NY / ACCESSWIRE / September 20, 2021 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.
LOS ANGELES, CA / ACCESSWIRE / September 20, 2021 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against CorMedix Inc. ("CorMedix" or "the Company") (NASDAQ:CRMD) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.